Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Vuocolo

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Expert Review of Vaccines|May 4, 2012
A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18Stephen E Goldstone, Scott Vuocolo
Journal of Cellular Physiology|March 25, 2004
p27/Kip1 mediates retinoic acid-induced suppression of ovarian carcinoma cell growthScott Vuocolo, Dianne Robert Soprano, Kenneth J Soprano
Neurodegenerative Disease Management|September 6, 2021
Inebilizumab for treatment of neuromyelitis optica spectrum disorderMark J Tullman, Aram Zabeti, Scott Vuocolo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRonald Marcus, Scott Vuocolo, Ian Ramsey, et al.
Sexually Transmitted Diseases|August 5, 2009
Prevalence and incidence of HPV genital infection in womenChristine Velicer, Xingshu Zhu, Scott Vuocolo, et al.
The International Journal of Neuropsychopharmacology|March 8, 2025
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trialsJonathan M Meyer, Ken Kramer, Scott Vuocolo, et al.
Clinical and Vaccine Immunology : CVI|April 21, 2012
Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccineKatie Matys, Sara Mallary, Oliver Bautista, et al.
The Journal of Biological Chemistry|August 14, 2003
Protein phosphatase 2A associates with Rb2/p130 and mediates retinoic acid-induced growth suppression of ovarian carcinoma cellsScott Vuocolo, Enkhtsetseg Purev, Dongmei Zhang, et al.
Human Vaccines & Immunotherapeutics|March 16, 2018
Vaccination strategies for the prevention of meningococcal diseaseScott Vuocolo, Paul Balmer, William C Gruber, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of ageTimo Vesikari, Pierre Van Damme, Niklas Lindblad, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Expert Review of Vaccines|May 4, 2012
A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18Stephen E Goldstone, Scott Vuocolo
Journal of Cellular Physiology|March 25, 2004
p27/Kip1 mediates retinoic acid-induced suppression of ovarian carcinoma cell growthScott Vuocolo, Dianne Robert Soprano, Kenneth J Soprano
Neurodegenerative Disease Management|September 6, 2021
Inebilizumab for treatment of neuromyelitis optica spectrum disorderMark J Tullman, Aram Zabeti, Scott Vuocolo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRonald Marcus, Scott Vuocolo, Ian Ramsey, et al.
Sexually Transmitted Diseases|August 5, 2009
Prevalence and incidence of HPV genital infection in womenChristine Velicer, Xingshu Zhu, Scott Vuocolo, et al.
The International Journal of Neuropsychopharmacology|March 8, 2025
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trialsJonathan M Meyer, Ken Kramer, Scott Vuocolo, et al.
Clinical and Vaccine Immunology : CVI|April 21, 2012
Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccineKatie Matys, Sara Mallary, Oliver Bautista, et al.
The Journal of Biological Chemistry|August 14, 2003
Protein phosphatase 2A associates with Rb2/p130 and mediates retinoic acid-induced growth suppression of ovarian carcinoma cellsScott Vuocolo, Enkhtsetseg Purev, Dongmei Zhang, et al.
Human Vaccines & Immunotherapeutics|March 16, 2018
Vaccination strategies for the prevention of meningococcal diseaseScott Vuocolo, Paul Balmer, William C Gruber, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of ageTimo Vesikari, Pierre Van Damme, Niklas Lindblad, et al.
Pageof 4